Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. (Q40005196)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Claudia S Vetter-Kauczok

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sonja Ortmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ulf R Rapp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Eva B Broecker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Juergen C Becker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

English

0 references

publication date

6 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

2003-2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323787%20AND%20SRC:MED&resulttype=core&format=json

Second nature: biological functions of the Raf-1 "kinase"

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Molecularly targeted therapy for melanoma: current reality and future options

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Seven-transmembrane receptor signalling and ERK compartmentalization.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2008.30

1 reference

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Untying the regulation of the Raf-1 kinase

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Regulation of iNOS by the p44/42 mitogen-activated protein kinase pathway in human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Oncogenic Ras in tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Examining the mechanism of Erk nuclear translocation using green fluorescent protein

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Anchorage-dependent ERK signaling--mechanisms and consequences

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Integrin regulation of cell signalling and motility.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Control of MAP kinase signaling to the nucleus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Signal transduction through MAP kinase cascades

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-inactivated tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

RKIP downregulates B-Raf kinase activity in melanoma cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

BuCy RAFs drive cells into MEK addiction

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

The role of scaffold proteins in MEK/ERK signalling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Signaling through focal adhesion kinase

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

BRAF mutation predicts sensitivity to MEK inhibition

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Cutaneous melanoma: available therapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

ERK regulation upon contact inhibition in fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Back to the roots: the remarkable RAF oncogene story

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021

Lack of association between BRAF V600E mutation and mitogen-activated protein kinase activation in papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.30

7 January 2021